Want to see GB:IHC full AI Analyst Report?
Inspiration Healthcare (IHC) AI Stock Analysis
Inspiration Healthcare
(LSE:IHC)
The stock’s mid-40s score is driven primarily by a mixed financial profile where recovering revenue and much stronger cash generation are offset by ongoing net losses, thin margins, and weakened equity, while a weak technical setup and limited valuation support further constrain the risk-reward outlook.
Inspiration Healthcare (IHC) vs. iShares MSCI United Kingdom ETF (EWC)
- Market Cap
- GBP 15.47M
- Dividend Yield
- ―
- Average Volume (3M)
- 30.18K
- Price to Earnings (P/E)
- -25.4
- Beta (1Y)
- -0.31
- Revenue Growth
- 0.88%
- EPS Growth
- 94.67%
- Country
- UK
- Employees
- 194
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Devices
Inspiration Healthcare Business Overview & Revenue Model
Company Description
Inspiration Healthcare Group plc (IHC.L) is a global provider of advanced medical technology, catering to critical care, operating theatre, and home healthcare applications worldwide. The company offers a comprehensive range of products, with a stron...
How the Company Makes Money
IHC makes money primarily by selling and distributing medical devices and related products to healthcare customers (typically hospitals and health systems). Revenue is generated from (1) product sales of medical equipment (including IHC-owned/control...
Inspiration Healthcare Financial Statement Overview
Summary
Revenue has recovered with stronger growth and cash flow has turned strongly positive, but the company remains loss-making with thin margins, volatile earnings, and materially eroded equity, leaving overall financial quality in the mid-range.
Income Statement
48NeutralBalance Sheet
42NeutralCash Flow
67Positive| Breakdown | TTM | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 45.60M | 47.55M | 38.25M | 37.63M | 41.23M | 41.05M |
| Gross Profit | 18.91M | 20.07M | 16.38M | 17.89M | 17.63M | 20.25M |
| EBITDA | 1.25M | 2.37M | -12.44M | -2.43M | 2.76M | 6.17M |
| Net Income | -608.00K | -1.04M | -14.97M | -6.03M | 272.00K | 4.23M |
Balance Sheet | ||||||
| Total Assets | 36.87M | 35.71M | 41.08M | 49.01M | 54.89M | 50.11M |
| Cash, Cash Equivalents and Short-Term Investments | 533.00K | 1.17M | 733.00K | 609.00K | 2.28M | 9.25M |
| Total Debt | 11.08M | 11.77M | 14.97M | 12.83M | 13.08M | 7.54M |
| Total Liabilities | 20.99M | 20.04M | 24.45M | 20.05M | 19.42M | 14.62M |
| Stockholders Equity | 15.88M | 15.67M | 16.64M | 28.97M | 35.47M | 35.49M |
Cash Flow | ||||||
| Free Cash Flow | 5.38M | 6.27M | -3.52M | 380.00K | -11.86M | -436.00K |
| Operating Cash Flow | 6.05M | 6.88M | -1.55M | 2.01M | -3.52M | 3.54M |
| Investing Cash Flow | -4.00M | -2.97M | -1.74M | -2.69M | -8.34M | -3.97M |
| Financing Cash Flow | -2.13M | -3.47M | 3.61M | -1.19M | 4.88M | -964.00K |
Inspiration Healthcare Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:IHC, the sentiment is Negative. The current price of 17.60 is below the 20-day moving average (MA) of 18.49, below the 50-day MA of 18.75, and below the 200-day MA of 21.29, indicating a bearish trend. The MACD of -0.13 indicates Positive momentum. The RSI at 29.54 is Positive, neither overbought nor oversold. The STOCH value of 16.94 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:IHC.
Inspiration Healthcare Peers Comparison
Overall Rating
GB:TSTL80Outperform
GB:SN72Outperform
GB:CTEC71Outperform
GB:AMS67Neutral- GB:IHC48.35Neutral
GB:SUN40Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| GB:TSTL | 80Outperform | GBP 194.70M | 24.28 | 23.05% | 3.51% | 10.02% | 19.83% |
| GB:SN | 72Outperform | GBP 9.27B | 19.52 | 12.25% | 2.66% | 2.17% | 27.33% |
| GB:CTEC | 71Outperform | GBP 4.67B | 51.64 | 8.40% | 2.28% | 1.94% | -43.71% |
| GB:AMS | 67Neutral | GBP 611.34M | 166.18 | 1.44% | 1.66% | 6.05% | -60.00% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| GB:IHC | 48Neutral | GBP 15.47M | -25.37 | -3.85% | ― | 0.88% | 94.67% |
| GB:SUN | 40Underperform | GBP 3.73M | -4.00 | -15.47% | ― | -3.68% | 20.00% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| GB:IHC | Inspiration Healthcare | 17.25 | -3.00 | -14.81% | |
| GB:AMS | Advanced Medical Solutions | 282.50 | 68.48 | 32.00% | |
| GB:CTEC | ConvaTec Group plc | 244.40 | 5.12 | 2.14% | |
| GB:SUN | Surgical Innovations Group Plc | 0.40 | -0.18 | -31.03% | |
| GB:TSTL | Tristel plc | 405.00 | 55.79 | 15.97% | |
| GB:SN | Smith & Nephew (UK) | 1107.50 | -272.82 | -19.76% |
Inspiration Healthcare Corporate Events
Inspiration Healthcare sets 27 October date for interim results and investor briefings
PositiveInspiration Healthcare Group plc will publish its unaudited interim results for the six months ended 31 July 2026 on 27 October 2026, underscoring a key reporting milestone for the AIM-quoted medical technology firm. The company is pairing the releas...
Inspiration Healthcare posts strong underlying growth as neonatal portfolio drives outlook ahead of forecasts
PositiveInspiration Healthcare reported revenue of £22.0 million for the six months to 31 July 2026, down from £24.0 million a year earlier due to the absence of £6.5 million of one-off export contracts booked in the prior period. Adjusted for...
Inspiration Healthcare grants performance-linked share options to top executives
PositiveInspiration Healthcare Group has granted 2,759,141 nil-cost share options under its Long-Term Incentive Plan, including substantial awards to chief executive Raffi Stepanian and chief financial officer Alan Olby. The grants comprise both performance-...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 18, 2026